RecruitingNot applicableNCT07317193
DEFINING THE GENETIC DRIVERS OF ADULT-ONSET CHOLESTATIC LIVER DISEASE
Studying Sclerosing cholangitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- Principal Investigator
- Luisa Ronzoni, Doctor
- Intervention
- Advanced Whole Genome Sequencing to Identify Rare Pathogenic Variants in Unexplained Cholestatic Liver Disease(other)
- Enrollment
- 60 enrolled
- Eligibility
- 18-65 years · All sexes
- Timeline
- 2025 – 2026
Study locations (1)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico - Istituto di Ricovero e Cura a Carattere Scientifico di natura pubblica, Milan, Milano, Italy
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07317193 on ClinicalTrials.govOther trials for Sclerosing cholangitis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT06825559Evaluate PK & Safety of Saroglitazar in Subjects With Moderate Hepatic Impairment Due to Cholestatic Liver DiseaseZydus Therapeutics Inc.
- RECRUITINGNCT06781242Genotype-phenotype Relationship Between Cryptogenic Cholestasis and Familial Intrahepatic CholestasisIRCCS Azienda Ospedaliero-Universitaria di Bologna
- ACTIVE NOT RECRUITINGNCT02545309Secondary Sclerosing Cholangitis in Critically Ill PatientsMedical University of Graz
- ACTIVE NOT RECRUITINGNANCT02601417The Necessity of Bile Cultures in Patients With Acute CholangitisSeoul National University Hospital